<main class="html-publication" lang="en" role="main">
      

  <div class="publication-external">
    <ul class="organisation-logos">
        <li class="organisation-logos__logo">
          
<div class="gem-c-organisation-logo brand--department-of-health">
    <a class="gem-c-organisation-logo__container gem-c-organisation-logo__link gem-c-organisation-logo__crest gem-c-organisation-logo__crest--single-identity brand__border-color" href="/government/organisations/uk-health-security-agency">
      <span class="gem-c-organisation-logo__name">UK Health<br>Security<br>Agency</span>
</a>
</div>
        </li>
    </ul>
  </div>

  <header class="gem-c-inverse-header  gem-c-inverse-header--padding-top ">
    
  

<div class="gem-c-title gem-c-title--inverse govuk-!-margin-top-8 govuk-!-margin-bottom-0">
      <span class="govuk-caption-xl gem-c-title__context">
    Guidance
  </span>


  <h1 class="gem-c-title__text govuk-heading-xl">
    Hepatitis B immunoglobulin (issued March 2021)
  </h1>
</div>
  <p class="publication-header__last-changed">Updated 4 May 2022</p>

  </header>



<div class="govuk-grid-row sidebar-with-body" data-module="sticky-element-container">
    <div class="govuk-grid-column-one-quarter-from-desktop contents-list-container">
        <nav aria-label="Contents" class="gem-c-contents-list" data-module="gem-track-click" role="navigation">
    <h2 class="gem-c-contents-list__title">
      Contents
</h2>
    <ol class="gem-c-contents-list__list">
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 1" data-track-category="contentsClicked" data-track-label="#overview" data-track-options="{&quot;dimension29&quot;:&quot;Overview&quot;}" href="#overview">Overview</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 2" data-track-category="contentsClicked" data-track-label="#indications" data-track-options="{&quot;dimension29&quot;:&quot;Indications&quot;}" href="#indications">Indications</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 3" data-track-category="contentsClicked" data-track-label="#dosage" data-track-options="{&quot;dimension29&quot;:&quot;Dosage&quot;}" href="#dosage">Dosage</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 4" data-track-category="contentsClicked" data-track-label="#administration" data-track-options="{&quot;dimension29&quot;:&quot;Administration&quot;}" href="#administration">Administration</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 5" data-track-category="contentsClicked" data-track-label="#recommendations" data-track-options="{&quot;dimension29&quot;:&quot;Recommendations&quot;}" href="#recommendations">Recommendations</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 6" data-track-category="contentsClicked" data-track-label="#post-exposure-for-individuals-who-have-been-vaccinated" data-track-options="{&quot;dimension29&quot;:&quot;Post-exposure for individuals who have been vaccinated&quot;}" href="#post-exposure-for-individuals-who-have-been-vaccinated">Post-exposure for individuals who have been vaccinated</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 7" data-track-category="contentsClicked" data-track-label="#post-exposure-for-non-responders" data-track-options="{&quot;dimension29&quot;:&quot;Post-exposure for non-responders&quot;}" href="#post-exposure-for-non-responders">Post-exposure for non-responders</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 8" data-track-category="contentsClicked" data-track-label="#guidance-for-issuers" data-track-options="{&quot;dimension29&quot;:&quot;Guidance for issuers&quot;}" href="#guidance-for-issuers">Guidance for issuers</a>

        </li>
    </ol>
</nav>
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>
    </div>

  <div class="print-wrapper">
    <div class="print-meta-data">
      <p>
  <img class="print-meta-data-licence" src="/assets/government-frontend/open-government-licence-min-93b6a51b518ff99714a1aa2a7d2162735c155ec3cb073c75fb88b2a332fa83d3.png">
</p>
<p>
  © Crown copyright 2022
</p>
<p>
  This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit <a href="https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3">nationalarchives.gov.uk/doc/open-government-licence/version/3</a> or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: <a href="mailto:psi@nationalarchives.gov.uk">psi@nationalarchives.gov.uk</a>.
</p>
<p>
  Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
</p>
<p>
  This publication is available at https://www.gov.uk/government/publications/immunoglobulin-when-to-use/hepatitis-b-immunoglobulin-issued-march-2021
</p>


    </div>
  </div>

  <div class="main-content-container">
    <div class="gem-c-govspeak-html-publication">
  
<div class="gem-c-govspeak govuk-govspeak " data-module="govspeak">
    
    
      <div class="govspeak">
<h2>Overview</h2>

<p>Human hepatitis B specific immunoglobulin (<abbr title="hepatitis B immunoglobulin">HBIG</abbr>) is supplied by Bio Products Laboratory (<abbr title="Bio Products Laboratory">BPL</abbr>) for post-exposure use to prevent hepatitis B infection.</p>

<p><abbr title="hepatitis B immunoglobulin">HBIG</abbr> is dispensed in vials of 500 IU.</p>

<p>Note: <abbr title="Bio Products Laboratory">BPL</abbr> is no longer supplying 200 IU vials of <abbr title="hepatitis B immunoglobulin">HBIG</abbr>.</p>

<h2>Indications</h2>

<p><abbr title="hepatitis B immunoglobulin">HBIG</abbr> is normally used in combination with hepatitis B vaccine to confer passive/active immunity in the following groups.</p>

<p>Newborn of mothers who are:</p>

<ul>
  <li>persistent carriers of hepatitis B surface antigen (<abbr title="hepatitis B surface antigen">HBsAg</abbr>), where hepatitis B e antigen (<abbr title="hepatitis B e antigen">HBeAg</abbr>) is detectable or its antibody (<abbr title="antibody to hepatitis B e antigen">Anti-HBe</abbr>) is not</li>
  <li>
<abbr title="hepatitis B surface antigen">HBsAg</abbr> positive and known to have a HBV DNA level equal to or above 1 x 10<sup>6</sup> IU/ml</li>
  <li>
<abbr title="hepatitis B surface antigen">HBsAg</abbr> positive as a result of recent acute infection</li>
  <li>
<abbr title="hepatitis B surface antigen">HBsAg</abbr> positive and the baby’s birth weight is 1,500g or less regardless of e-antigen status or HBV DNA (viral load) of mother</li>
</ul>

<p>Accidental exposure by blood or other material known to contain <abbr title="hepatitis B surface antigen">HBsAg</abbr> through:</p>

<ul>
  <li>percutaneous inoculation (needlestick or other ‘sharp’, bites, scratches)</li>
  <li>contamination of mucous membranes (spillage into eyes or mouth)</li>
  <li>contamination of non-intact skin (open wounds, dermatitis or eczema)</li>
  <li>the virus does not cross intact skin</li>
</ul>

<p>Sexual contacts:</p>

<ul>
  <li>of individuals suffering from acute hepatitis B who are seen within 1 week of last
contact should be offered <abbr title="hepatitis B immunoglobulin">HBIG</abbr> and vaccine</li>
  <li>of individuals with newly diagnosed chronic hepatitis B should be offered vaccine – <abbr title="hepatitis B immunoglobulin">HBIG</abbr> may be given in addition if unprotected sexual contact occurred in the past 7 days</li>
  <li>other exposed contacts get vaccine only</li>
</ul>

<h2>Dosage</h2>

<p>Dosage is as follows:</p>

<ul>
  <li>0 to 4 years – 250 i.u. (approximately 1.75ml or half of a 500 i.u. vial)*</li>
  <li>5 to 9 years – 300 i.u.</li>
  <li>=&gt;10 years – 500 i.u.</li>
</ul>

<p>*If stockholders still hold 200 i.u. vials, the whole vial can be used for 0 to 4 years old until stocks are exhausted. Please then use the dosages above for 500 i.u. vials.</p>

<h2>Administration</h2>

<p><abbr title="hepatitis B immunoglobulin">HBIG</abbr> should be given by intramuscular injection at the same time as vaccine (but different site) as soon as possible, preferably within 24 hours and ideally within 48 hours – but no later than a week after exposure.</p>

<p>Hepatitis B vaccine should never be delayed while waiting for <abbr title="hepatitis B immunoglobulin">HBIG</abbr> administration.</p>

<h2>Recommendations</h2>

<h3>Newborns</h3>

<p>Babies are considered ‘high risk’ of maternal-to-child transmission and should receive <abbr title="hepatitis B immunoglobulin">HBIG</abbr> and vaccine if:</p>

<ul>
  <li>mother is <abbr title="hepatitis B surface antigen">HBsAg</abbr> seropositive and <abbr title="hepatitis B e antigen">HBeAg</abbr> positive</li>
  <li>mother is <abbr title="hepatitis B surface antigen">HBsAg</abbr> seropositive and <abbr title="hepatitis B e antigen">HBeAg</abbr>/anti-HBe negative</li>
  <li>mother is <abbr title="hepatitis B surface antigen">HBsAg</abbr> seropositive and e markers are not available</li>
  <li>mother has acute hepatitis B in pregnancy</li>
  <li>mother is <abbr title="hepatitis B surface antigen">HBsAg</abbr> seropositive and infant is born weighing 1,500g or less</li>
  <li>mother is <abbr title="hepatitis B surface antigen">HBsAg</abbr> seropositive and known to have an HBV DNA level equal to or above 1 x 10<sup>6</sup> IU/ml in any antenatal sample in this pregnancy</li>
</ul>

<p>Babies receive hepatitis B vaccine but do not receive <abbr title="hepatitis B immunoglobulin">HBIG</abbr> if none of the above criteria for newborns apply, for example if the mother is anti-HBe positive and <abbr title="hepatitis B e antigen">HBeAg</abbr> negative and newborn does not have a low birthweight.</p>

<h2>Post-exposure for individuals who have been vaccinated</h2>

<p>Individuals who have already been fully vaccinated with a primary course and had a significant exposure to a known <abbr title="hepatitis B surface antigen">HBsAg</abbr> source should be given a booster dose of hepatitis B vaccine (without immunoglobulin) unless booster given within past year.</p>

<p>For those who have been partially vaccinated, 1 dose of vaccine should be given and the course completed.</p>

<h2>Post-exposure for non-responders</h2>

<p>Health care workers who have received a full course of hepatitis B vaccine and have not responded (&lt;10 IU/ml) should be given <abbr title="hepatitis B immunoglobulin">HBIG</abbr> post exposure.</p>

<p>Serum for <abbr title="hepatitis B surface antigen">HBsAg</abbr> should be obtained from the source.</p>

<p>A second dose of immunoglobulin should be administered 1 month after the first unless the source is shown to be <abbr title="hepatitis B surface antigen">HBsAg</abbr> negative</p>

<h2>Guidance for issuers</h2>

<ol>
  <li>
    <p>Requests for <abbr title="hepatitis B immunoglobulin">HBIG</abbr> for neonates (both advanced and emergency issue) must be accompanied by an issuing form. The issuing form is available on the Hepatitis B page of <a class="govuk-link" href="https://www.gov.uk/government/publications/hepatitis-b-requesting-issue-of-immunoglobulin-for-infants">GOV.UK</a>.</p>
  </li>
  <li>
    <p><abbr title="hepatitis B immunoglobulin">HBIG</abbr> will be issued where 1 or more of the e-markers are unknown. If in doubt issue, as delay in administration could reduce the chances of preventing transmission.</p>
  </li>
  <li>
    <p>Vaccine is the most important intervention and this should be carried out as soon as possible and not delayed whilst awaiting <abbr title="hepatitis B immunoglobulin">HBIG</abbr> or test results.</p>
  </li>
  <li>
    <p><abbr title="hepatitis B immunoglobulin">HBIG</abbr> immunoglobulin is not available for the treatment of any type of chronic hepatitis B infection.</p>
  </li>
  <li>
    <p>It is not available for travellers to high endemicity areas – vaccine should be considered.</p>
  </li>
  <li>
    <p><abbr title="hepatitis B immunoglobulin">HBIG</abbr> immunoglobulin will not inhibit the antibody response when given at the same time as hepatitis B vaccine but should be given in different sites.</p>
  </li>
  <li>
    <p>Further information on the use of passive immunisation with <abbr title="hepatitis B immunoglobulin">HBIG</abbr> for infants born to hepatitis B-infected mothers is available on <a class="govuk-link" href="https://www.gov.uk/government/collections/hepatitis-b-guidance-data-and-analysis#infants-born-to-hepatitis-b-infected-mothers">GOV.UK</a>.</p>
  </li>
  <li>
    <p>Full guidance on hepatitis B prophylaxis for reported exposure incidents is in <a class="govuk-link" href="https://www.gov.uk/government/publications/hepatitis-b-the-green-book-chapter-18">The Green Book, chapter 18: Hepatitis B</a>.</p>
  </li>
</ol>

</div>


</div>
</div>
  </div>

  <div class="sticky-element" data-sticky-element="">
    <a class="govuk-link app-c-back-to-top dont-print" href="#contents">
    <svg class="app-c-back-to-top__icon" focusable="false" height="17" viewBox="0 0 13 17" width="13" xmlns="http://www.w3.org/2000/svg">
      <path d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z" fill="currentColor"></path>
    </svg>
    Contents
</a>

    <div class="sticky-element__print-link">
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>
    </div>
  </div>
</div>

    </main>